Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.9.2153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Combination of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Required for Resistance to the Carbocyclic Nucleoside 1592U89.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, With Protease Inhibitor Therapy and in Vitro Drug Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Pharmacokinetic Interaction of Abacavir (1592U89) and Ethanol in Human Immunodeficiency Virus-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Synergistic Inhibition of Human Immunodeficiency Virus in Vitro by Azidothymidine and Recombinant Alpha a Interferon.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy